Skip to main content

StimAire concludes injectable stimulator study for OSA

Oct. 12, 2023

Neuromodulation company StimAire, which collaborated with researchers at the College of Medicine – Tucson, has concluded the first-in-human study of an injectable stimulator for obstructive sleep apnea in Australia.